Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,575 | 390 | 92.3% |
| Education | $719.25 | 9 | 7.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,641 | 78 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,135 | 41 | $0 (2024) |
| Lilly USA, LLC | $1,040 | 49 | $0 (2024) |
| GENZYME CORPORATION | $928.23 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $776.70 | 41 | $0 (2024) |
| ABBVIE INC. | $720.74 | 42 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $531.02 | 23 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $389.49 | 15 | $0 (2024) |
| UCB, Inc. | $308.73 | 18 | $0 (2024) |
| PFIZER INC. | $193.15 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,374 | 114 | Janssen Biotech, Inc. ($529.93) |
| 2023 | $3,343 | 130 | Janssen Biotech, Inc. ($774.29) |
| 2022 | $2,260 | 86 | E.R. Squibb & Sons, L.L.C. ($414.88) |
| 2021 | $1,318 | 69 | GENZYME CORPORATION ($246.70) |
All Payment Transactions
399 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.83 | General |
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $42.99 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.13 | General |
| Category: Immunology | ||||||
| 11/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Immunology | ||||||
| 10/23/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: DERMATOLOGY | ||||||
| 10/14/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: Dermatology | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Immunology | ||||||
| 09/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,638 | 3,001 | $399,744 | $102,499 |
| 2022 | 12 | 1,407 | 2,512 | $340,264 | $89,331 |
| 2021 | 13 | 963 | 1,490 | $219,851 | $64,016 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 330 | $83,107 | $24,324 | 29.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 224 | 274 | $72,629 | $18,978 | 26.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 282 | 361 | $56,475 | $10,213 | 18.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 190 | $32,443 | $9,860 | 30.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 65 | 85 | $29,068 | $9,266 | 31.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 140 | 164 | $38,314 | $7,915 | 20.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 126 | 126 | $31,883 | $6,879 | 21.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 218 | 1,272 | $19,576 | $5,509 | 28.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 37 | 40 | $12,530 | $3,020 | 24.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 64 | 65 | $6,694 | $2,230 | 33.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 34 | 42 | $5,289 | $1,465 | 27.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 19 | 19 | $5,864 | $1,431 | 24.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $5,826 | $1,396 | 24.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 19 | $46.36 | $13.54 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 282 | $71,019 | $20,827 | 29.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 169 | 196 | $51,954 | $14,305 | 27.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 76 | 94 | $32,146 | $9,737 | 30.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 235 | 292 | $45,680 | $8,790 | 19.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 133 | 153 | $35,744 | $8,047 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 136 | $23,222 | $7,025 | 30.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 129 | 129 | $32,642 | $6,817 | 20.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 188 | 1,065 | $16,390 | $4,877 | 29.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 57 | 74 | $9,319 | $2,707 | 29.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 19 | 22 | $9,155 | $2,364 | 25.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 21 | 28 | $8,771 | $2,329 | 26.6% |
About Keeley Diggs
Keeley Diggs is a Physician Assistant healthcare provider based in Easton, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2020. The National Provider Identifier (NPI) number assigned to this provider is 1316558216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Keeley Diggs has received a total of $9,294 in payments from pharmaceutical and medical device companies, with $2,374 received in 2024. These payments were reported across 399 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($8,575).
As a Medicare-enrolled provider, Diggs has provided services to 4,008 Medicare beneficiaries, totaling 7,003 services with total Medicare billing of $255,846. Data is available for 3 years (2021–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Easton, MD
- Active Since 08/13/2020
- Last Updated 08/13/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316558216
Products in Payments
- TREMFYA (Drug) $1,408
- DUPIXENT (Biological) $1,398
- Sotyktu (Drug) $1,049
- TALTZ (Drug) $874.90
- SKYRIZI (Biological) $449.24
- REMICADE (Biological) $373.31
- COSENTYX (Drug) $311.72
- Cimzia (Drug) $275.21
- RINVOQ (Biological) $208.69
- EUCRISA (Drug) $193.15
- ILUMYA (Biological) $181.31
- VTAMA (Drug) $161.65
- Flexitouch Plus (Device) $143.38
- ADBRY (Biological) $138.18
- Ilumya (Biological) $117.87
- KRYSTEXXA (Biological) $110.25
- EPSOLAY (Drug) $107.82
- OLUMIANT (Drug) $102.63
- Otezla (Drug) $91.94
- LIBTAYO (Biological) $89.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Easton
Melissa Haggerty
Physician Assistant — Payments: $8,731
Amy Engler, Pa, PA
Physician Assistant — Payments: $7,793
Erica Franks, Pa-C, PA-C
Physician Assistant — Payments: $5,994
Fallon Bauer, Pa-C, PA-C
Physician Assistant — Payments: $4,721
Nicholas Lumi, Pa-C, PA-C
Physician Assistant — Payments: $2,427
Maria Georgalas, Pac, PAC
Physician Assistant — Payments: $1,654